Immunoassays

The PhoenixDx® SARS-CoV-2 Neutralizing Antibody Test Kit (ELISA) is used for the in vitro qualitative detection of neutralizing antibodies (nAb) against RBD of Novel Coronavirus (SARS-CoV-2) S1 protein in human serum or plasma.

real-time RT-PCR-based diagnostic test for the in vitro qualitative detection and discrimination of SARS-CoV-2, Delta and Omicron.

Cardiolipin-Check is a solid phase enzyme immunoassay employing highly purified cardiolipin plus native human ß2-glycoprotein I for the combined quantitative detection of IgA, IgG and IgM antibodies against cardiolipin in human serum.

Cardiolipin-GM is a solid phase enzyme immunoassay employing highly purified cardiolipin plus native human ß2-glycoprotein I for the quantitative detection of IgG and /or IgM vantibodies against cardiolipin in human serum.

β2-Glyco-GM is a solid phase enzyme immunoassay employing native β2-glycoproteinI highly purified from human plasma for the separate quantitative detection of IgG and / or IgM antibodies against β2-glycoprotein I in human serum.

Serine-GM is a solid phase enzyme immunoassay with highly purified phosphatidyl-serine plus native human ß2-glycoprotein I for the quantitative detection of IgG and/ or IgM antibodies against phosphatidyl-serine in human serum.

Inositol-GM is a solid phase enzyme immunoassay with highly purified phosphatidyl-inositol plus native human beta2-glycoprotein I for the quantitative detection of IgG and/ or IgM antibodies against phosphatidyl-inositol in human serum.

Ethanolamin-GM is a solid phase enzyme immunoassay with highly purified phosphatidylethanolamin plus native human ß2 glycoprotein I for the quantitative detection of IgG and/orIgM antibodies against phosphatidyl-ethanolamin in human serum.

Cholin-GM is a solid phase enzyme immunoassay with highly purified phosphatidyl-cholin and native human ß2-glycoprotein I for the quantitative detection of IgG and/or IgM antibodies against phosphatidyl-cholin in human serum.

β2-Glyco-Check is a solid phase enzyme immunoassay employing native β2-glycoproteinI highly purified from human plasma for the combined quantitative detection of IgA, IgG and IgM antibodies against β2-glycoprotein I in human serum.